Beam Therapeutics Inc. (BEAM) vs Precigen, Inc. (PGEN)
Beam Therapeutics Inc. and Precigen, Inc. are both Biotechnology companies. Beam Therapeutics Inc. and Precigen, Inc. are of similar size ($2.8B and $2.6B). Precigen, Inc. grew revenue faster over the last twelve months: 1,875.1% against 158.9%. Beam Therapeutics Inc. has the higher net margin (−55.5% vs −392.8%) and the lower return on invested capital (−1,599.3% vs −24.9%). Across the 18 metrics below, Beam Therapeutics Inc. leads on 12 and Precigen, Inc. on 6.
Valuation
Profitability
| Metric | BEAM | PGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 90.67% | 65.16% |
| Operating margin | (242.27%) | (46.08%) | 0.00% |
| Net margin | (55.45%) | (392.81%) | 0.00% |
| Free cash flow margin | (238.90%) | (134.42%) | 0.00% |
| Return on equity | (8.18%) | (9,907.46%) | (57.72%) |
| Return on assets | (6.23%) | (247.40%) | (49.22%) |
| Return on invested capital | (1,599.30%) | (24.87%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack